Pharmacotherapy of scleritis: current paradigms and future directions
Authors:
- 21 February 2013
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 14 (4) , 411-424
Abstract
Introduction: Scleritis is an inflammatory condition affecting the eye wall that may be associated with a number of systemic inflammatory diseases. Because scleritis can be refractory to standard t...Keywords
This publication has 134 references indexed in Scilit:
- Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitisJournal of Ophthalmic Inflammation and Infection, 2012
- Early surgical debridement in the management of infectious scleritis after pterygium excisionJournal of Ophthalmic Inflammation and Infection, 2012
- Long-Term, Multicenter Evaluation of Subconjunctival Injection of Triamcinolone for Non-Necrotizing, Noninfectious Anterior ScleritisOphthalmology, 2011
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- Cyclosporine for Ocular Inflammatory DiseasesOphthalmology, 2010
- Mycophenolate Mofetil for Ocular InflammationAmerican Journal of Ophthalmology, 2010
- Cyclophosphamide for Ocular Inflammatory DiseasesOphthalmology, 2010
- Methotrexate for Ocular Inflammatory DiseasesOphthalmology, 2009
- Azathioprine for Ocular Inflammatory DiseasesAmerican Journal of Ophthalmology, 2009
- Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label studyAnnals of the Rheumatic Diseases, 2009